nevanac
novartis europharm limited - nepafenaka - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
yellox
bausch + lomb ireland limited - bromfenak natrij seskvihidrat - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - liječenje postoperativne očne upale nakon ekstrakcije katarakta kod odraslih osoba.
uniclophen 0,1% 1 mg/1 ml kapi za oči, rastvor
tuzlafarm d.o.o. tuzla - diklofenak - kapi za oči, rastvor - 1 mg/1 ml - 1 ml kapi za oči, rastvora sadrži: 1 mg diklofenaknatrijuma
rediclon 0,1% 1 mg/1 ml kapi za oko, otopina
unifarm d.o.o. lukavac - diklofenak - kapi za oko, otopina - 1 mg/1 ml - 1 bočica sa 0,3 ml kapi za oko, otopine sadrži: 0,3 mg diklofenak natrijuma (1 mg/ml)
rediclon 0,1% 1 mg/1 ml kapi za oko, otopina
unifarm d.o.o. lukavac - diklofenak - kapi za oko, otopina - 1 mg/1 ml - 1 bočica sa 0,3 ml kapi za oko, otopine sadrži 0,3 mg diklofenak natrijuma (1 mg/ml)
naclof 1 mg/ml kapi za oko, otopina
novartis hrvatska d.o.o., radnička cesta 37b, zagreb, hrvatska - diklofenaknatrij - kapi za oko, otopina - urbroj: 1 ml otopine sadrži 1 mg diklofenaknatrija
nevanac 1 mg/1 ml kapi za oko, suspenzija
novartis ba d.o.o. - nepafenak - kapi za oko, suspenzija - 1 mg/1 ml - 1 ml kapi za oko, suspenzije sadrži: 1 mg nepafenaka
prepandrix
glaxosmithkline biologicals s.a. - a / indonesia / 05/2005 (h5n1) kao soj koji se koristio (pr8-ibcdc-rg2) - influenza, human; immunization; disease outbreaks - cjepiva - aktivna imunizacija protiv h5n1 podtipa virusa gripe a. ovaj prikaz se temelji na imunogenosti podataka od zdravih ispitanika u dobi od 18 i dalje godina nakon uvođenja dvije doze cjepiva, kuhani s podtipa h5n1 sojeva . prepandrix mora se koristiti u skladu sa službenim vodstvom.
hemocue wbc microcuvettes
inel - medicinska tehnika d.o.o. orehovečki brijeg 2 10000 zagreb -
jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.